NCT04913649View on ClinicalTrials.gov

Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Ferric Derisomaltose 100 MG/ML

Postoperative treatment with a single dose IVI (ferric derisomaltose), with a dose of 20mg/kg in approximately 60 minutes.

DRUG

Sodium chloride

Postoperative treatment with a single dose NaCl 0.9% in approximately 60 minutes.

Trial Locations (2)

Unknown

RECRUITING

Amphia Hospital, Breda

RECRUITING

St Antonius Hospital, Nieuwegein

Sponsors

Collaborators (1)

Pharmacosmos A/S
All Listed Sponsors
collaborator

Pharmacosmos A/S

INDUSTRY

lead

dr. P. Noordzij

OTHER

NCT04913649 - Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter